Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
27,995,500
-
Total 13F shares
-
12,030,506
-
Share change
-
+1,115,444
-
Total reported value
-
$177,148,772
-
Price per share
-
$14.72
-
Number of holders
-
64
-
Value change
-
+$16,402,387
-
Number of buys
-
47
-
Number of sells
-
11
Institutional Holders of Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) as of Q3 2017
As of 30 Sep 2017,
Syros Pharmaceuticals, Inc. - Common Stock, $0.001 par value (SYRS) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,030,506 shares.
The largest 10 holders included
FMR LLC, DEERFIELD MANAGEMENT CO, WELLINGTON MANAGEMENT GROUP LLP, Redmile Group, LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., VANGUARD GROUP INC, Aisling Capital LLC, PRICE T ROWE ASSOCIATES INC /MD/, and Cormorant Asset Management, LLC.
This page lists
64
institutional shareholders reporting positions in this security
for the Q3 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.